Lang Xie

Lang Xie

Auto-generated profile, based on publicly available information

Lang Xie

Department of Hospital Infection Management and Preventive Health Care, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2025 in Medicine
Verified
Journal Article
Open access
HLHongzhou Liu
Hongzhou Liu
LXLang Xie
Lang Xie
YSYi Shen
Yi Shen
YDYangfan Du
Yangfan Du
JLJia Liu
Jia Liu
SDSong Dong
Song Dong
Thyroid cancer, particularly prevalent among women of childbearing age (WCBA), presents a growing global public health concern. This study examines the global, regional, and national burden of WCBA thyroid cancer from 1990 to 2021, with an emphasis on socioeconomic factors, including high body mass index. Data were drawn from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. We analyzed incidence, prevalence, disability-adjusted life years, and mortality rates for WCBA thyroid cancer, focusing on age-standardized rates. Temporal trends were quantified using the average annual percentage change. Inequalities were assessed using the concentration index; locally estimated scatterplot smoothing modeled age-standardized rate–sociodemographic index (SDI) relationships; decomposition identified contributions of population growth, aging, and epidemiologic change. From 1990 to 2021, the global incidence of WCBA thyroid cancer increased with an average annual percent change (AAPC) of 1.4% (95% confidence interval [CI]: 1.32–1.48), while prevalence rose at an AAPC of 1.44% (95% CI: 1.37–1.52). Conversely, the age-standardized mortality rate declined annually by 0.28% (95% CI: −0.4 to −0.16), and disability-adjusted life years showed no significant change (AAPC = −0.01, 95% CI: −0.18 to 0.17). The highest increase in disease burden was observed in low and low-middle SDI regions, with mortality rates linked to high body mass index rising by 2.19% annually. In contrast, high-SDI regions experienced a decrease in burden, with annual reductions in mortality rates ranging from 1.13% to 0.34%. Rising WCBA thyroid cancer incidence and prevalence, particularly in low SDI regions, highlight the urgent need for targeted prevention and health management strategies.

28 December 2024 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
LLLei Liu
Lei Liu
QZQiao Zhang
Qiao Zhang
SJShuai Jin
Shuai Jin
LXLang Xie
Lang Xie
Although the Tumor-Node-Metastasis (TNM) staging system is widely used for staging lung squamous cell carcinoma (LSCC), the TNM system primarily emphasizes tumor size and metastasis, without adequately considering lymph node involvement. Consequently, incorporating lymph node metastasis as an additional prognostic factor is essential for predicting outcomes in LSCC patients. This retrospective study included patients diagnosed with LSCC between 2004 and 2018 and was based on data from the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute. The primary endpoint of the study was cancer-specific survival (CSS), and demographic characteristics, tumor characteristics, and treatment regimens were incorporated into the predictive model. The study focused on the value of indicators related to pathological lymph node testing, including the lymph node ratio (LNR), regional node positivity (RNP), and lymph node examination count (RNE), in the prediction of cancer-specific survival in LSCC. A prognostic model was established using a multivariate Cox regression model, and the model was evaluated using the C index, Kaplan–Meier, the Akaike information criterion (AIC), decision curve analysis (DCA), continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI), and the predictive efficacy of different models was compared. A total of 14,200 LSCC patients (2004–2018) were divided into training and validation cohorts. The 10-year CSS rate was approximately 50%, with no significant survival differences between cohorts (p = 0.8). The prognostic analysis revealed that models incorporating LNR, RNP, and RNE demonstrated superior performance over the TNM model. The LNR and RNP models demonstrated better model fit, discrimination, and reclassification, with AUC values of 0.695 (training) and 0.665 (validation). The RNP and LNR models showed similar predictive performance, significantly outperforming the TNM and RNE models. Calibration curves and decision curve analysis confirmed the clinical utility and net benefit of the LNR and RNP models in predicting long-term CSS for LSCC patients, highlighting their value in clinical decision-making. This study confirms that RNP status is an independent prognostic factor for CSS in LSCC, with predictive efficacy comparable to LNR, with both models enhancing survival prediction beyond TNM staging.